Ceo & Founder
CurrentPherDal Fertility Science, creators of the first and only sterile at-home insemination kit, is officially accepting orders of its patented intravaginal insemination (IVI) device, following the awarding of FDA clearance in December 2023. The PherDal Kit is the only sterile, FDA-cleared, at-home insemination kit for people struggling to conceive or have chosen not to conceive through intercourse. PherDal is an affordable, over-the-counter fertility treatment and the only one to combine the sterile environment of the fertility clinic with the at-home capabilities of insemination. Rooted in science and holding multiple utility patents, The PherDal Kit bridges the gap between traditional conception and more invasive options with a sterile syringe that goes deep into the vagina to deliver sperm directly to the opening of the cervix while bypassing bacterial or anatomical interference. After 16 months of unexplained infertility, our founder, Dr. Jennifer Hintzsche, used her Ph.D. in Biology and her husband’s mechanical engineering skills to invent a medical device that conceived their daughter in just the second month of use. PherDal’s 200 proof-of-concept kits sold out in 90 days, with 34 reported pregnancies. A successful crowdfunding equity campaign further validated the company’s impressive growth and potential, securing over $630K for FDA clearance testing. In 2023, CEO Dr. Jennifer Hintzsche was named an emerging innovator at the Life Science Intelligence USA event, one of LEK's FemTech companies to watch, and was a finalist at the prestigious SXSW Pitch competition. With a dedicated team of medical, legal, and health tech experts, PherDal Fertility Science is revolutionizing reproductive medicine by introducing the first and only sterile, FDA-cleared, over-the-counter fertility treatment offered without a prescription. Now available to order exclusively at PherDal.com.